Order results by:
| Issue | Title | |
| Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
| M. M. Batiushin | ||
| "... on the nephroprotective properties of mineralocorticoid receptor antagonists, endothelin receptor antagonists, and sodium ..." | ||
| Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya | ||
| "... of ideas about cardio-, vaso- and nephroprotective effects of these drugs is highlighted as well ..." | ||
| Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
| A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
| "... . Most patients with CKD receive nephroprotective therapy with RASi and statins according to current ..." | ||
| Vol 4, No 2 (2008) | FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva | ||
| "... Calcium antagonists (CA) therapy of patients with arterial hypertension is focused on the base ..." | ||
| Vol 3, No 2 (2007) | CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS | Abstract similar documents |
| D. V. Nebieridze | ||
| "... The efficacy of calcium antagonists widely used in cardiological practice is proved both ..." | ||
| Vol 20, No 2 (2024) | Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect | Abstract similar documents |
| O N. Kurochkina, D. A. Korotkov, A. S. Sazhina, A N. Bogomolov | ||
| "... indicates that the progression of chronic heart failure (CHF) and chronic kidney disease (CKD) involves ..." | ||
| Vol 2, No 4 (2006) | CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY | Abstract similar documents |
| R. I. Striuk | ||
| "... should be used immediately. Dihydropyridine calcium antagonists (CA) is drugs of choice for HT treatment ..." | ||
| Vol 11, No 2 (2015) | A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE | Abstract similar documents |
| B. B. Gegenava, O. M. Drapkina | ||
| "... of the selective antagonist of mineralocorticoid receptor eplerenone are analyzed. The advantages of eplerenone ..." | ||
| Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS | Abstract similar documents |
| Y. A. Karpov, V. V. Buza | ||
| "... . Advantages of dihydropyridine calcium antagonists (DPCA) for AH treatment in elderly patients are proved ..." | ||
| Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
| "... Приведены классификация, механизмы действия и клинические эффекты применения антагонистов кальция ..." | ||
| Vol 16, No 4 (2020) | Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist | Abstract PDF (Eng) similar documents |
| S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary | ||
| "... Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure ..." | ||
| Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
| S. V. Nedogoda | ||
| "... Results of randomized clinical trials on the usage of calcium antagonists (CA) in order to prevent ..." | ||
| Vol 7, No 3 (2011) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE | Abstract similar documents |
| A. A. Garganeeva | ||
| Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
| E. V. Shilova, S. Y. Martsevich | ||
| "... Classification of calcium antagonists (CA) is presented. Results of the large clinical trials ..." | ||
| Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
| T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
| Vol 19, No 4 (2023) | Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy | Abstract similar documents |
| S. R. Gilyarevsky, D. O. Ladygina | ||
| "... , despite the normal blood pressure level. Modern data on the role of mineralocorticoid receptor antagonists ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... diseases (CVD), but also the prevention and treatment of chronic kidney disease (CKD). The fact ..." | ||
| Vol 6, No 1 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION | Abstract similar documents |
| S. A. Boitsov, R. M. Linchak | ||
| "... attention is paid to usage of ACE inhibitor and calcium antagonist combination. ..." | ||
| Vol 6, No 3 (2010) | EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| D. A. Yakhontov, N. F. Balabanova | ||
| "... of the second group received any other antihypertensive therapy except dihydropyridine calcium antagonists ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... + diet), group A2 (ACE inhibitor + fluvastatin), group B1 (angiotensin II receptor antagonist (ARA II ..." | ||
| Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
| V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
| "... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..." | ||
| Vol 10, No 4 (2014) | TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE | Abstract similar documents |
| O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov | ||
| Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... and angiotensin II receptor antagonists (ARA) in patients with COVID-19 is analyzed in the article ..." | ||
| Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
| E. I. Emelina, G. E. Gendlin | ||
| "... Рассматриваются особенности и возможности применения в кардиологической практике антагониста ..." | ||
| Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya | ||
| "... receptor antagonist (ARA), valsartan at the cardiovascular continuum (CVC) stages. Material and methods ..." | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The classification of calcium antagonists is presented. There were considered the results of large ..." | ||
| Vol 13, No 4 (2017) | PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY | Abstract similar documents |
| O. M. Drapkina, D. U. Akasheva | ||
| "... with reduced ejection fraction (<40%). Antagonists of mineralocorticoid receptors, along with angiotensin ..." | ||
| Vol 6, No 5 (2010) | NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION | Abstract similar documents |
| O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya | ||
| "... . Показаны преимущества комбинации ингибитора ангиотензин-превращающего фермента с антагонистом кальция в ..." | ||
| Vol 5, No 3 (2009) | FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY | Abstract similar documents |
| O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova | ||
| Vol 3, No 2 (2007) | CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS | Abstract similar documents |
| V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina | ||
| "... antagonists (ARA II) – candesartan (Atacand) and losartan (Cosaar) in patients with chronic cor pulmonale (CCP ..." | ||
| Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
| O. D. Ostroumova, I. I. Kopchenov | ||
| "... converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the efficacy ..." | ||
| Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
| I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
| "... decade. Prevalence of AF among patients with chronic kidney disease (CKD) varies from 11 to 22 ..." | ||
| Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
| N. A. Dzhaiani | ||
| "... disease are presented. Special attention is paid to the fixed combination of calcium antagonist ..." | ||
| Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
| Vol 14, No 4 (2018) | Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases | Abstract similar documents |
| O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin | ||
| "... with atrial fibrillation (AF) are of leading importance. Recently, non-vitamin K antagonist oral ..." | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
| A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
| "... to clinical guidelines vitamin K antagonists (VKAs) should be used as treatment of choice for thrombus ..." | ||
| Vol 20, No 4 (2024) | Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension | Abstract similar documents |
| O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova | ||
| "... receptor antagonist spironolactone. However, the inclusion of this drug in antihypertensive therapy ..." | ||
| Vol 10, No 1 (2014) | ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES | Abstract similar documents |
| J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili | ||
| "... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..." | ||
| Vol 15, No 4 (2019) | According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention | Abstract similar documents |
| Company Pfizer | ||
| Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
| A. V. Rodionov | ||
| "... , calcium antagonists, mainly amlodipine, have the greatest potential for the variability reduction ..." | ||
| Vol 14, No 2 (2018) | NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY | Abstract similar documents |
| S. G. Shulkina, Е. N. Smirnova | ||
| Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova | ||
| "... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... kidney diseases (CKD) and the development of cardiovascular complications. Immune and non-immune ..." | ||
| Vol 15, No 2 (2019) | Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice | Abstract similar documents |
| E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova | ||
| "... using CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration Formula), changes in BP. Patients ..." | ||
| Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
| D. A. Napalkov, E. N. Golovenko | ||
| Vol 12, No 1 (2016) | Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) | Abstract PDF (Eng) similar documents |
| E. L. Trisvetova, S. V. Gubkin | ||
| "... , specific therapy with calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists ..." | ||
| Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... inhibitor and antagonist of angiotensin II receptor are discussed. ..." | ||
| Vol 17, No 6 (2021) | Renal Function Protection as an Important Component of a Comprehensive Approach to the Management of Patients with Atrial Fibrillation | Abstract similar documents |
| T. V. Pavlova | ||
| "... kidney disease (CKD) are two diseases that can coexist in a patient. The risk of ac thromboembolic ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... 4 or 5 chronic kidney disease" or "stage 5 chronic kidney disease" and "non-vitamin K antagonist ..." | ||
| Vol 12, No 2 (2016) | CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva | ||
| "... and instrumental investigation. Renal function was assessed using the CKD-EPI formula to calculate glomerular ..." | ||
| Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... pressure control and positive cardioprotective and nephroprotective effect. ..." | ||
| Vol 10, No 3 (2014) | ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... . In order to assess the nephroprotective properties, the following end points were selected: the incidence ..." | ||
| Vol 12, No 4 (2016) | Renal filtration function in patients with gout | Abstract similar documents |
| N. N. Kushnarenko, T. A. Medvedeva, A. V. Govorin, M. Yu. Mishko | ||
| "... , glomerular filtration rate (GFR) was evaluated by CKD-EPI method. Depending on GFR level, all the patients ..." | ||
| Vol 17, No 3 (2021) | New Possibilities in Quantitative Assessment of Albuminuria in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract PDF (Eng) similar documents |
| A. A. Sokolova, A. I. Skripka, I. I. Ivanov, V. V. Kogay, A. I. Listratov, A. A. Gindis, D. A. Napalkov | ||
| "... -hours urine spots and chronic kidney disease (CKD) progression pace in patients with atrial fibrillation ..." | ||
| Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract similar documents |
| Yu. M. Lopatin | ||
| "... Обсуждаются антиатеросклеротические свойства дигидропиридинового антагониста кальция амлодипина у ..." | ||
| Vol 13, No 3 (2017) | HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
| O. A. Kislyak, A. V. Starodubova, A. A. Kopelev | ||
| "... ожирением. Обосновывается целесообразность использования в данной клинической ситуации антагонистов кальция ..." | ||
| Vol 7, No 3 (2011) | TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR | Abstract similar documents |
| I. M. Sokolov | ||
| "... недигидропиридиновых антагонистов кальция (АК). Акцент сделан на представителе недигидропиридиновых АК — верапамиле ..." | ||
| Vol 2, No 1 (2006) | ARE ALL THE PROLONGED DRUG FORMULATIONS OF NIFEDIPINE THE SAME? | Abstract similar documents |
| V. G. Kukes, D. A. Sychev | ||
| "... Publication is devoted to the calcium antagonist nifedipine in drug formulations of the prolonged ..." | ||
| Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
| S. A. Boytsov, I. P. Kolos | ||
| "... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..." | ||
| Vol 13, No 5 (2017) | ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT | Abstract similar documents |
| S. G. Kanorskii | ||
| "... of anticoagulant therapy include vitamin K antagonists, such as warfarin, whose benefits are long established ..." | ||
| Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... изучались эффективность и безопасность современного антагониста кальция (АК) лерканидипина. Результаты ..." | ||
| Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
| "... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| "... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..." | ||
| Vol 11, No 6 (2015) | The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev | ||
| "... – chronic obstructive pulmonary disease, bronchial asthma and chronic kidney disease (CKD). Results ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of platelet receptors ..." | ||
| Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
| L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
| "... Ингибиторы ангиотензинпревращающего фермента (иАПФ) и антагонисты рецепторов к ангиотензину (АРА ..." | ||
| Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
| M. A. Ninci, R. Magliocca, A. Malliani | ||
| "... Цель. Оценить эффективность лерканидипина (антагониста кальция из группы дигидропиридинов) у ..." | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... АПФ (ИАПФ) и антагонистов рецепторов ангиотензина (АРА) на исходы сердечно-сосудистых заболеваний ..." | ||
| Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| Vol 3, No 5 (2007) | CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich | ||
| Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| N. M. Nikitina, A. P. Rebrov | ||
| "... into account wide usage of non steroid antiinflammatory drugs calcium antagonists or angiotensin II receptor ..." | ||
| Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
| A. V. Rudenko, B. A. Rudenko | ||
| "... Amlodipine combines the most important clinical effects of calcium antagonists with minimal side ..." | ||
| Vol 14, No 4 (2018) | New Clinical Aspects of Eplerenone Use in Clinical Practice | Abstract similar documents |
| S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina | ||
| "... of mineralocorticoid receptor antagonists in patients with heart failure with reduced left ventricular ejection ..." | ||
| Vol 13, No 5 (2017) | Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells | Abstract similar documents |
| Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov | ||
| "... profile of drug interaction in comparison to other non-vitamin K antagonist oral anticoagulants (NOAC ..." | ||
| Vol 9, No 3 (2013) | THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS | Abstract similar documents |
| M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Цель. Изучить эффективность и безопасность антагониста кальция, S-амлодипина, в комбинации с бета ..." | ||
| Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
| M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
| Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 9, No 6 (2013) | POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK | Abstract similar documents |
| Z M. Sizova | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... ) the following types of antithrombotic therapy are used: anticoagulant therapy with vitamin K antagonists ..." | ||
| Vol 17, No 2 (2021) | Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran | Abstract PDF (Eng) similar documents |
| N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev | ||
| "... . It is a complicated issue for any doctor to prescribe the anticoagulant therapy for patients with AF and CKD. 30 ..." | ||
| Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
| S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
| "... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..." | ||
| Vol 18, No 5 (2022) | Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review | Abstract similar documents |
| B. A. Tatarsky, N. V. Kazennova | ||
| "... with atrial fibrillation. Direct oral anticoagulants have replaced vitamin K antagonists: either direct ..." | ||
| Vol 2, No 2 (2006) | PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING | Abstract similar documents |
| N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich | ||
| "... %, beta-blockers – 28%, diuretics – 26% and calcium antagonists – 10%. Other classes of antihypertensive ..." | ||
| Vol 18, No 3 (2022) | Dynamics of 6-Minute Walk Distance as a Predictor of Efficiency Specific Pulmonary Vasodilators | Abstract similar documents |
| A. A. Shmalts | ||
| "... . Approved specific therapy with five classes of drugs – prostanoids, endothelin receptor antagonists ..." | ||
| Vol 13, No 5 (2017) | ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM – CASE REPORT | Abstract similar documents |
| S. D. Klimovskiy, G. G. Gazaryan, M. D. Krichman, P. B. Pisetskiy, A. G. Koledinskiy, T. Sh. Mirilashvili | ||
| "... important practical significance, due to the prevailing benefit of calcium antagonists in the treatment ..." | ||
| Vol 7, No 3 (2011) | COGNITIVE-MNESTIC FUNCTIONS IN ABLE-BODIED AGED PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION IN AMLODIPINE TREATMENT | Abstract similar documents |
| N. N. Ilov, R. N. Shvarts, T. N. Panova | ||
| "... . Monotherapy with calcium channels antagonist, amlodipine, improves CMF in patients with EAH. Amlodipine has ..." | ||
| Vol 16, No 6 (2020) | The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? | Abstract similar documents |
| N. M. Vorobyeva, O. N. Tkacheva | ||
| "... , rivaroxaban, apixaban, and edoxaban) over the vitamin K antagonist warfarin in elderly patients with geriatric ..." | ||
| Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
| O. V. Averkov, L. N. Mishchenko | ||
| "... antagonists (warfarin) as well as direct oral anticoagulants (DOAC): dabigatran, rivaroxaban, apixaban ..." | ||
| Vol 19, No 6 (2023) | Acute kidney injury as a risk factor for atrial fibrillation after coronary artery bypass grafting — effects of sodium-glucose cotransporter-2 inhibitors | Abstract similar documents |
| L. V. Kremneva, L. A. Arutyunyan, L. I. Gapon, S. N. Suplotov, S. V. Shalaev | ||
| "... (CKD) — 23,9%, preprocedural pAF — 10,9%, previous myocardial infarction (MI) — 54,3%. Off-pump CABG ..." | ||
| Vol 13, No 5 (2017) | THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION | Abstract similar documents |
| M. V. Kurkina, A. G. Avtandilov, I. A. Krutovcev | ||
| "... , diabetes mellitus, chronic kidney disease (CKD), length of illness) leading to the formation of chronic ..." | ||
| Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
| "... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..." | ||
| Vol 18, No 4 (2022) | Refractory Arterial Hypertension: Features of Neurohormonal and Water-salt Imbalanceand Approaches to Antihypertensive Drug Therapy | Abstract similar documents |
| O. B. Kuzmin, V. V. Zhezha | ||
| "... longacting diuretic chlorthalidone and the mineralcorticoid receptor antagonists (spironolactone ..." | ||
| Vol 6, No 2 (2010) | REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT | Abstract similar documents |
| A. N. Britov, M. M. Bystrova | ||
| "... with the aldosterone antagonist. Improvement of patient compliance is one of key factors of effective treatment. ..." | ||
| Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
| O. D. Ostroumova, I. V. Goloborodova | ||
| "... the effects of unfractionated heparin, low molecular weight heparins, vitamin K antagonists, oral ..." | ||
| Vol 15, No 3 (2019) | Hypertension and Headache: the Effect of Antihypertensive Drugs | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova | ||
| "... -blockers, ACEI, ARB, diuretics, while calcium antagonists did not reduce the frequency of headaches ..." | ||
| Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
| "... and angiotensin II receptor antagonists in the prevention of AF is revealed. RAAS blockers are able not only ..." | ||
| Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
| Yu. A. Bunin, S. V. Miklishanskaya | ||
| "... of them oral anticoagulants were used mainly from the group of vitamin K antagonists, most often warfarin ..." | ||
| 1 - 100 of 194 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
